VIRGINIA BEACH, Va.,
Jan. 13, 2021 /PRNewswire/ -- LifeNet
Health announced today the launch of their newly expanded
LifeSciences division which is offering human cell- and
tissue-based research solutions through a new website,
LNHLifeSciences.org.
LifeNet Health has industry-leading recovery, handling and
preservation protocols — assuring tissue integrity and quality are
sustained throughout the entire process. The organization offers
expertise with the recovery of an extensive range of healthy and
diseased human biospecimens which are preserved to meet the
customized needs of each researcher.
The scientific community can now view the portfolio, explore
informative resources such as publications, product information,
and webinars, as well as request a quote at
LNHLifeSciences.org.
"We are offering something new to researchers as the only fully
vertically integrated provider of human-derived cells, models and
biospecimens for scientific discovery," said Louis Dias, Vice President and General Manager
of LifeNet Health LifeSciences. "We are able to provide human
cell-based research solutions with controlled variables from
beginning to end."
LifeNet Health LifeSciences applies precise control to allow
human primary liver cells to be carefully curated and fully
individuated with extensive characterization. All cells are
meticulously documented with up to 337 data points recorded
throughout the process — ensuring highly annotated cells that
closely parallel in vivo conditions.
Researchers have access to LifeNet Health's scientists for
peer-to-peer consultation to assist with selecting specific cells
that will most closely match each individual's needs. LifeNet
Health's available inventory includes more than 200 lots of primary
human liver cells, including hepatocytes, stellate, Kupffer and
endothelial cells, from both healthy and diseased tissue. Each lot
is accompanied by a comprehensive certificate of analysis,
including histopathology assessment by a board-certified
pathologist.
"The data obtained by using these human-based tools will provide
crucial information to better guide drug development," said
Rony Thomas, LifeNet Health
President and CEO. "Using the technologies and expertise we have
developed in biologics; we are empowering the life sciences
industry by improving the predictive power of research for the
development of the most efficacious and safest therapies."
About LifeNet Health
LifeNet Health helps save lives,
restore health, and give hope to thousands each year. It is the
world's most trusted provider of transplant solutions — from organ
procurement to bio-implants and cellular therapies — and a leader
in regenerative medicine, while always honoring the donors and
healthcare professionals who enable healing. For more information
about LifeNet Health, go to www.lifenethealth.org.
View original
content:http://www.prnewswire.com/news-releases/lifenet-health-launches-newly-expanded-lifesciences-division-with-innovative-solutions-for-researchers-301207808.html
SOURCE LifeNet Health